PALIFERMIN IS A HUMAN RECOMBINANT KERATINOCYTE GROWTH FACTOR (KGF) THAT BINDS TO THE KGF RECEPTOR, AND IS REPORTED TO PRODUCE PROLIFERATION, DIFFERENTIATION, AND MIGRATION OF EPITHELIAL CELLS. PALIFERMIN IS USED TO REDUCE THE INCIDENCE AND DURATION OF SEVERE ORAL MUCOSITIS IN PATIENTS WITH HAEMATOLOGICAL NEOPLASMS UNDERGOING MYELOTOXIC CHEMOTHERAPY, WITH OR WITHOUT RADIOTHERAPY, BEFORE HAEMATOPOIETIC STEM CELL TRANSPLANTATION.